Topic List : Cardiovascular Health
Drug reduces kidney failure in diabetics
Canagliflozin, a drug approved to lower glucose levels in diabetic patients, can slow the progression of kidney disease, according to a study co-authored by a Stanford Medicine researcher.
Identifying familial hypercholesterolemia
Stanford scientists and their collaborators have devised an algorithm to predict the risk of a disease that, untreated, can lead to heart attack or stroke.
Mystery novel and dream spur key insight
On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the thinking in his field about what causes a common and often lethal heart defect.
Apple Heart Study demonstrates ability of wearable technology to detect atrial fibrillation
Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.
Discovery could limit toxic effect of chemo
Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.
Heart defects boost heart disease risk
Even a relatively simple heart defect makes a patient much more likely to develop cardiovascular disease as an adult, Stanford researchers say.
Big victory for a tiny heart
With no blood flow to his right lung, infant Carter Johnson was diagnosed with a rare condition called absent right pulmonary artery. His parents turned to Stanford Children’s Health for help.
Spotty statin adherence leads to higher mortality
Patients who took statins less than 70 percent of the time had a 20 percent increase in mortality compared with those taking them at least 90 percent of the time, a Stanford study found.
Compound may help treat heart failure
In preliminary tests, SAMβA (pronounced “samba”) appears to improve heart functions in rats with heart failure caused by a heart attack.
Promoting artery growth to damaged heart tissue
Stanford scientists have discovered a molecule that promotes the growth of collateral arteries in mice. The finding could open the door to developing therapies that help heal heart tissues damaged by disease or heart attack in humans.